Back
BeiGene Vs. Cytokinetics Industry Stock Comparison
Sell
37
BGNE
BeiGene
Last Price:
162.82
Seasonality Move:
14.67%
Buy
55
CYTK
Cytokinetics
Last Price:
53.96
Seasonality Move:
7.55%
Sell
37
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $162.58. The Score for BGNE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BGNE Stock Price Chart
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $53.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.
BGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.32 | Buy |
| Relative Strength Index (14 RSI): | 54.18 | Buy |
| Chaikin Money Flow: | 27471 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (152.83 - 167.57) | Buy |
| Bollinger Bands (100): | (145.5 - 166.46) | Buy |
CYTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.04 | Sell |
| Relative Strength Index (14 RSI): | 46.58 | Sell |
| Chaikin Money Flow: | 781761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.51 - 58.99) | Sell |
| Bollinger Bands (100): | (57.71 - 76.51) | Sell |
BGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160.63 | Buy |
| 20-day SMA: | 159.25 | Buy |
| 50-day SMA: | 154.5 | Buy |
| 200-day SMA: | 169.58 | Sell |
| 8-day EMA: | 161.12 | Buy |
| 20-day EMA: | 159.23 | Buy |
| 50-day EMA: | 157.9 | Buy |
| 200-day EMA: | 169.64 | Sell |
CYTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.47 | Buy |
| 20-day SMA: | 52.83 | Buy |
| 50-day SMA: | 60.85 | Sell |
| 200-day SMA: | 55.3 | Sell |
| 8-day EMA: | 53.07 | Buy |
| 20-day EMA: | 54.08 | Sell |
| 50-day EMA: | 58.8 | Sell |
| 200-day EMA: | 57.11 | Sell |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.93 per share, an increase next quarter of $0.95 per share, a decrease this year of $0.33 per share, and an increase next year of $5.07 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.
BeiGene Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cytokinetics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||